Mesenchymal Cell News 12.13 April 7, 2020 | |
| |
TOP STORYAs MSC behavior is influenced by the properties of engineered hydrogels, the authors hypothesized that the biochemical and biophysical properties of alginate could be manipulated to promote the dual contributions of encapsulated MSCs toward bone formation. [Biomaterials] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROTopography Induced Stiffness Alteration of Stem Cells Influences Osteogenic Differentiation Investigators showed that topography had a significant influence on single cell stiffness of human bone marrow derived-MSCs and their osteogenic differentiation. [Biomater Sci] Full Article | Graphical Abstract Osteoblastic Differentiation on Graphene Oxide-Functionalized Titanium Surfaces: An In Vitro Study Researchers evaluated dental pulp stem cell viability, cytotoxic response, and osteogenic differentiation capability in the presence of graphene oxide-coated titanium surfaces. [Nanomaterials] Full Article Bone marrow-derived MSCs transfected with Indian Hedgehog siRNA showed characteristics of senescence-associated features including increased senescence-associated β-galactosidase activity, induction of cell cycle inhibitors, development of senescence-associated secretory phenotype, activation of ROS and mTOR pathways as well as the promotion of skewed differentiation. [Aging (Albany NY)] Full Article The authors observed that irradiated bone marrow MSCs lost typical fibroblast-like morphology, exhibited suppressed viability and differentiation potential accompanied with senescence phenotypes, including an increase in senescence-associated β-galactosidase staining-positive cells and up-regulated senescence related genes p53/p21, while none changes happened to p16. [Am J Physiol Cell Physiol] Abstract Whereas adipose-derived MSCs (ASCs) were generally unaffected by high-glucose (HG), HG caused a reduction of the angiogenic potential in human retinal microvascular endothelial cells. Increased oxidative stress levels appeared to be linked to the HG-induced reduction of angiogenesis, which could be restored by ASC-conditioned medium and antioxidant treatment. [Cytotherapy] Abstract IN VIVOPluronic F-127 (PF-127) was found to be cytotoxic to Wharton’s jelly MSCs (WJMSCs) while sodium ascorbyl phosphate significantly improved the survival of PF-127-embedded WJMSCs. [Stem Cell Res Ther] Full Article Investigators determined whether stable expression of hepatic growth factor (HGF) in bone marrow MSCs coupled with ultrasound-targeted microbubble destruction technique could effectively and definitely alleviating carbon tetrachloride-induced liver fibrosis in rats. [Stem Cell Res Ther] Full Article Morphological Changes in Synovial Mesenchymal Stem Cells during Their Adhesion to the Meniscus Researchers quantified the proportion of human synovial MSCs that adhered to a porcine abraded meniscus, clarified their morphological changes, and revealed the mechanism by which the synovial MSCs adhered to the meniscus. [Lab Invest] Abstract Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSScientists discuss the current knowledge of MSC metabolism and how it may be optimized along with the current and future uses of genome scale constraint based metabolic modeling to further this aim. [Front Bioeng Biotechnol] Full Article Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSCitius Pharmaceuticals, Inc. signed an exclusive six-month option agreement to in-license a stem-cell therapy for ARDS from a subsidiary of Novellus, Inc. Novellus’s patented process uses its exclusive non-immunogenic synthetic messenger ribonucleic acid molecules to create induced pluripotent stem cells that, in turn, generate MSCs with superior immunomodulatory properties. [Citius Pharmaceuticals, Inc.] Press Release FDA Approval to Commence First Stem Cell Clinical Trial for Protection against COVID-19 Hope Biosciences announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adipose-derived MSCs to provide immune support against COVID-19. [Hope Biosciences] Press Release | |
| |
POLICY NEWSScientists Around the Globe Pivot Their Research to SARS-CoV-2 Numerous groups around the world have diverted their skills and resources to help stop the pandemic. While the majority of research at academic institutions grinds to a halt, some labs have kept their lights on to conduct coronavirus-related experiments. [The Scientist] Editorial Safely Conducting Essential Research in the Face of COVID-19 Some scientists can’t simply stop going to their laboratories — especially not those who are overseeing clinical trials that could offer life-saving vaccines and therapies, particularly against the new coronavirus. And some research activities must continue even in the face of a shutdown. [Nature News] Editorial NIH’s Process for Removing Reviewers Remains a Mystery, Watchdog Finds A new report by the Office of Inspector General of National Institute of Health’s (NIH’s) parent body, the Department of Health and Human Services, documents how NIH has begun to remove reviews who breached NIH standards on research integrity. [ScienceInsider] Editorial
| |
EVENTSIn light of COVID-19, many conferences are being cancelled or postponed. As such: We are suspending new event postings in our newsletters and on Twitter. Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW PhD Student – Bioprinting of Tissues (Uppsala University) NEW Postdoctoral Positions – Systems Biology and Metabolism (Charité – Universitätsmedizin Berlin) Assistant Professor – Sarcoma (McGill University) Professor – Molecular Physiology (Karolinska Institutet) Postdoctoral Fellowship – Bone Repair (Johns Hopkins University School of Medicine) Postdoctoral Scholar – Cancer Research in Sarcoma (The Ohio State University) Postdoctoral Associate – Cartilage Regeneration (Drexel University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|